Francesca Zanoni

ORCID: 0000-0001-9567-6713
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Renal Diseases and Glomerulopathies
  • Renal Transplantation Outcomes and Treatments
  • Chronic Kidney Disease and Diabetes
  • Antioxidant Activity and Oxidative Stress
  • Diabetes and associated disorders
  • Genetic Associations and Epidemiology
  • Algal biology and biofuel production
  • Dialysis and Renal Disease Management
  • Celiac Disease Research and Management
  • Microencapsulation and Drying Processes
  • Central Venous Catheters and Hemodialysis
  • Proteins in Food Systems
  • Phytochemicals and Antioxidant Activities
  • Vascular Procedures and Complications
  • Systemic Sclerosis and Related Diseases
  • Vasculitis and related conditions
  • Systemic Lupus Erythematosus Research
  • Phase Change Materials Research
  • Frailty in Older Adults
  • Catalysts for Methane Reforming
  • Liver Disease Diagnosis and Treatment
  • COVID-19 Clinical Research Studies
  • Parathyroid Disorders and Treatments
  • Adsorption and Cooling Systems
  • Acute Kidney Injury Research

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
2017-2025

Columbia University
2019-2025

Istituti di Ricovero e Cura a Carattere Scientifico
2020-2024

Columbia University Irving Medical Center
2020-2024

University of Pennsylvania
2021-2024

Ospedale Maggiore
2019-2024

New York University
2024

Sorbonne Université
2022

University of Verona
2016-2020

The green alga Chlamydomonas reinhardtii does not synthesize high-value ketocarotenoids like canthaxanthin and astaxanthin; however, a β-carotene ketolase (CrBKT) can be found in its genome. CrBKT is poorly expressed, contains long C-terminal extension homologues likely represents pseudogene this alga. Here, we used synthetic redesign of gene to enable constitutive overexpression from the nuclear genome C. reinhardtii. Overexpression optimized extended native carotenoid biosynthesis generate...

10.1111/pbi.13364 article EN cc-by Plant Biotechnology Journal 2020-02-25
Krzysztof Kiryluk Elena Sánchez Shufeng Zhou Francesca Zanoni Lili Liu and 95 more Nikol Mladkova Atlas Khan Maddalena Marasà Jun Y. Zhang Olivia Balderes Simone Sanna‐Cherchi Andrew S. Bomback Pietro A. Canetta Gerald B. Appel Jai Radhakrishnan Hernán Trimarchi Ben Sprangers Daniel Cattran Heather N. Reich York Pei Pietro Ravani Kres̆imir Gales̃ić Dita Maixnerová Vladimı́r Tesař Bénédicte Stengel Marie Metzger Guillaume Canaud Nicolas Maillard F. Berthoux Laureline Berthelot Évangéline Pillebout Renato C. Monteiro Raoul D. Nelson Robert Wyatt William E. Smoyer John D. Mahan Al-Akash Samhar Guillermo Hidalgo Alejandro Quiroga Patricia L. Weng Raji Sreedharan David T. Selewski Keefe Davis Mahmoud Kallash Tetyana L. Vasylyeva Michelle N. Rheault Aftab S. Chishti Daniel Ranch Scott E. Wenderfer Dmitry Samsonov Donna Claes Oleh M. Akchurin Dimitrios Goumenos Μaria Stangou Judit Nagy Tibor Kovács Enrico Fiaccadori Antonio Amoroso Cristina Barlassina Daniele Cusi Lucia Del Vecchio Giovanni Giorgio Battaglia Monica Bodria Emanuela Boer Luisa Bono Giuliano Boscutti Gianluca Caridi Francesca Lugani Gian Marco Ghiggeri Rosanna Coppo Licia Peruzzi Vittoria Esposito Ciro Esposito Sandro Feriozzi Rosaria Polci Giovanni M. Frascà Marco Galliani Maurizio Garozzo Adele Mitrotti Loreto Gesualdo Simona Granata Gianluigi Zaza Francesco Londrino Riccardo Magistroni Isabella Pisani Andrea Magnano Carmelita Marcantoni Piergiorgio Messa Renzo Mignani Antonello Pani Claudio Ponticelli Dario Roccatello Maurizio Salvadori Erica Salvi Domenico Santoro Guido Gembillo Silvana Savoldi Donatella Spotti Pasquale Zamboli Claudia Izzi

10.1038/s41588-023-01422-x article EN Nature Genetics 2023-06-19

Addition of different types phase change materials (PCMs) to cement-based for thermal energy storage has been broadly investigated in the literature. Many studies have researched addition organic PCMs and performance PCM-cement system. However, drawbacks such as leakage poor conductivity stimulated improve properties within Among solutions, carbonous (such graphite carbon nanotubes) investigated. In current work, an innovative system that contains microencapsulated (MPCMs) purposely...

10.1016/j.est.2024.110675 article EN cc-by Journal of Energy Storage 2024-02-15

Background Frailty is common in older patients affected by chronic kidney disease (CKD). Since gut microbiota (gMB) may contribute to frailty, we explored possible associations between gMB and frailty CKD. Methods We studied 64 CKD (stage 3b-4), categorized as frail (F, 38) not (NF, 26) according Fried criteria, 15 controls (C), all than 65 years. In assessed serum C-reactive protein, blood neutrophil/lymphocyte ratio, Malnutrition-inflammation Score (MIS); was denaturing gel gradient...

10.1371/journal.pone.0228530 article EN cc-by PLoS ONE 2020-04-01

Abstract Chronic Kidney Disease (CKD) represents a slowly progressive disorder that is typically silent until late stages, but early intervention can significantly delay its progression. We designed portable and scalable electronic CKD phenotype to facilitate disease recognition empower large-scale observational genetic studies of kidney traits. The algorithm uses combination rule-based machine-learning methods automatically place patients on the staging grid albuminuria by glomerular...

10.1038/s41746-021-00428-1 article EN cc-by npj Digital Medicine 2021-04-13

Immunoglobulin A (IgA) mediates mucosal responses to food antigens and the intestinal microbiome is involved in susceptibility pathogens, celiac disease, inflammatory bowel IgA nephropathy. We performed a genome-wide association study of serum levels 41,263 individuals diverse ancestries identified 20 significant loci, including 9 known 11 novel loci. Co-localization analyses with expression QTLs prioritized candidate genes for 14 Most loci encoded that produced immune defects abnormalities...

10.1038/s41467-022-34456-6 article EN cc-by Nature Communications 2022-11-11

Astaxanthin (ASX) is a carotenoid of great interest due to its potential health benefits. However, use in the food, feed, and pharmaceutical fields limited low bioavailability, poor stability during thermochemical treatments, susceptibility oxidation, organoleptic characteristics. The aim this work was develop method stabilize astaxanthin extracted from microalgae Haematococcus pluvialis (H.p.) improve nutritional functional properties through nanoencapsulation. Nanoparticles (NPs) were...

10.3390/md17110627 article EN cc-by Marine Drugs 2019-11-04

Sarcopenia is a prevalent condition in chronic kidney disease (CKD). We determined gut microbiota (gMB) composition CKD patients with or without sarcopenia. Furthermore, we investigated whether these patients, there was any association between gMB, uremic toxins, inflammation and oxidative stress. analyzed gMB composition, toxins (indoxyl sulphate p-cresyl sulphate), inflammatory cytokines (interleukin 10, tumor necrosis factor α, interleukin 6, 17, 12 p70, monocyte chemoattractant protein-1...

10.3390/toxins13070472 article EN cc-by Toxins 2021-07-08

Summary Astaxanthin (ASX) is a carotenoid characterised by numerous health‐promoting properties but biased scarce chemical stability. Our aim was to microencapsulate ASX through ionic gelation improve its stability and bioaccessibility, evaluating the performance of low‐methoxyl pectin (LMP) chitosan, besides most common alginate. Three formulations were tested: 3% (Pec), + chitosan shell (PecChi) 1.5% alginate—1.5% LMP shell. The results showed that deposited onto PecAlChi PecChi beads...

10.1111/ijfs.16389 article EN cc-by International Journal of Food Science & Technology 2023-03-01

Significance Statement Vesicoureteral reflux (VUR) is associated with progressive kidney disease. Familial aggregation supports a hereditary basis; however, its genetic architecture remains to be elucidated. The largest VUR copy number variant analysis and genome-wide association study date accounts for multiple modes of inheritance sex-specific effects in VUR, identifying three study-wide significant five suggestive loci large effects, containing canonical developmental genes including...

10.1681/asn.2020050681 article EN Journal of the American Society of Nephrology 2021-02-17

BACKGROUNDIt is unknown whether the risk of kidney disease progression and failure differs between patients with without genetic disorders.METHODSThree cohorts were evaluated: prospective Cure Glomerulonephropathy Network (CureGN) 2 retrospective from Columbia University, including 5,727 adults children any etiology who underwent whole-genome or exome sequencing. The effects monogenic disorders APOL1 kidney-risk genotypes on failure, estimated glomerular filtration rate (eGFR) decline,...

10.1172/jci178573 article EN cc-by Journal of Clinical Investigation 2024-09-02

Background: A family history of health conditions may reflect shared genetic and/or environmental risk. It is not well known to what extent impacts outcomes among patients with chronic kidney disease (CKD). Herein, we studied the associations CKD, diabetes, and other common comorbidities progression CKD. Methods: We carried out an observational study two prospective CKD cohorts, 2,573 adults children from Cure Glomerulopathy Network (CureGN) 3,939 Chronic Renal Insufficiency Cohort (CRIC)...

10.1681/asn.0000000653 article EN Journal of the American Society of Nephrology 2025-03-11

Central venous catheter use is rising in chronic and acute hemodialysis. Catheter-related bloodstream infections are a major complication of central use. This article examines clinical factors associated with catheter-related incidence.In this retrospective, single-center study, 413 patients undergoing extracorporeal treatments between 1 February 2014 31 January 2017 560 catheters were recruited. Clinical parameters, such as gender, age, kidney disease status, diabetes, immunosuppression,...

10.1177/1129729820939762 article EN The Journal of Vascular Access 2020-07-10
Coming Soon ...